×
About 613 results

ALLMedicine™ Pseudomonas Aeruginosa Infections Center

Research & Reviews  297 results

Carriage of two carbapenem-resistance genes in Pseudomonas aeruginosa isolated from hos...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082860
Antimicrobial Resistance and Infection Control; Pérez-Corrales C, Peralta-Barquero V et. al.

Apr 29th, 2021 - The assessment of Hospital-acquired infections due to multidrug-resistant bacteria involves the use of a variety of commercial and laboratory-developed tests to detect antimicrobial resistance genes in bacterial pathogens; however, few are evaluat...

Gene-gene interactions dictate ciprofloxacin resistance in Pseudomonas aeruginosa and f...
https://doi.org/10.1128/AAC.02696-20
Antimicrobial Agents and Chemotherapy; Rehman A, Jeukens J et. al.

Apr 20th, 2021 - Ciprofloxacin is one of the most widely used antibiotics for treating Pseudomonas aeruginosa infections. However P. aeruginosa acquires mutations that confer ciprofloxacin resistance, making treatment more difficult. Resistance is multifactorial, ...

Failed eradication therapy of new onset Pseudomonas aeruginosa infections in cystic fib...
https://doi.org/10.1093/infdis/jiab102
The Journal of Infectious Diseases; Kwong K, Benedetti A et. al.

Feb 19th, 2021 - Antibiotics, such as inhaled tobramycin are used to eradicate new onset Pseudomonas aeruginosa (PA) infections in cystic fibrosis (CF) patients but frequently fail due to reasons poorly understood. We hypothesized that PA isolates' resistance to n...

Skin manifestations of Pseudomonas aeruginosa infections.
https://doi.org/10.1097/QCO.0000000000000717
Current Opinion in Infectious Diseases; Spernovasilis N, Psichogiou M et. al.

Jan 25th, 2021 - Pseudomonas aeruginosa is an opportunistic pathogen with considerable morbidity and mortality, particularly in vulnerable hosts. Skin manifestations are common, either representing local inoculation or secondary skin seeding following bloodstream ...

Outbreak of Pseudomonas aeruginosa Infections from a Contaminated Gastroscope Detected ...
https://doi.org/10.1093/cid/ciaa1887
Clinical Infectious Diseases : an Official Publication Of... Sundermann AJ, Chen J et. al.

Dec 28th, 2020 - Traditional methods of outbreak investigations utilize reactive whole genome sequencing (WGS) to confirm or refute the outbreak. We have implemented WGS surveillance and a machine learning (ML) algorithm for the electronic health record (EHR) to r...

see more →

Guidelines  2 results

International Consensus Guidelines for the Optimal Use of the Polymyxins
https://accpjournals.onlinelibrary.wiley.com/doi/full/10.1002/phar.2209

Feb 1st, 2019 - The polymyxin antibiotics colistin (polymyxin E) and polymyxin B became available in the 1950s and thus did not undergo contemporary drug development procedures. Their clinical use has recently resurged, assuming an important role as salvage thera...

Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinet...
http://www.who.int/infection-prevention/publications/guidelines-cre/en/
WHO

Oct 31st, 2017 - Health care-associated infections (HAI) are one of the most common adverse events in care delivery. A large proportion are caused by antibiotic resistant organisms.

see more →

Clinicaltrials.gov  307 results

Carriage of two carbapenem-resistance genes in Pseudomonas aeruginosa isolated from hos...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082860
Antimicrobial Resistance and Infection Control; Pérez-Corrales C, Peralta-Barquero V et. al.

Apr 29th, 2021 - The assessment of Hospital-acquired infections due to multidrug-resistant bacteria involves the use of a variety of commercial and laboratory-developed tests to detect antimicrobial resistance genes in bacterial pathogens; however, few are evaluat...

Gene-gene interactions dictate ciprofloxacin resistance in Pseudomonas aeruginosa and f...
https://doi.org/10.1128/AAC.02696-20
Antimicrobial Agents and Chemotherapy; Rehman A, Jeukens J et. al.

Apr 20th, 2021 - Ciprofloxacin is one of the most widely used antibiotics for treating Pseudomonas aeruginosa infections. However P. aeruginosa acquires mutations that confer ciprofloxacin resistance, making treatment more difficult. Resistance is multifactorial, ...

Failed eradication therapy of new onset Pseudomonas aeruginosa infections in cystic fib...
https://doi.org/10.1093/infdis/jiab102
The Journal of Infectious Diseases; Kwong K, Benedetti A et. al.

Feb 19th, 2021 - Antibiotics, such as inhaled tobramycin are used to eradicate new onset Pseudomonas aeruginosa (PA) infections in cystic fibrosis (CF) patients but frequently fail due to reasons poorly understood. We hypothesized that PA isolates' resistance to n...

Skin manifestations of Pseudomonas aeruginosa infections.
https://doi.org/10.1097/QCO.0000000000000717
Current Opinion in Infectious Diseases; Spernovasilis N, Psichogiou M et. al.

Jan 25th, 2021 - Pseudomonas aeruginosa is an opportunistic pathogen with considerable morbidity and mortality, particularly in vulnerable hosts. Skin manifestations are common, either representing local inoculation or secondary skin seeding following bloodstream ...

Outbreak of Pseudomonas aeruginosa Infections from a Contaminated Gastroscope Detected ...
https://doi.org/10.1093/cid/ciaa1887
Clinical Infectious Diseases : an Official Publication Of... Sundermann AJ, Chen J et. al.

Dec 28th, 2020 - Traditional methods of outbreak investigations utilize reactive whole genome sequencing (WGS) to confirm or refute the outbreak. We have implemented WGS surveillance and a machine learning (ML) algorithm for the electronic health record (EHR) to r...

see more →

News  7 results

Filamentous bacteriophage linked to lung infections in patients with cystic fibrosis
https://www.mdedge.com/internalmedicine/article/199114/pulmonology/filamentous-bacteriophage-linked-lung-infections?channel=27970
Steve Cimino

Apr 18th, 2019 - Filamentous bacteriophage (Pf phage) may contribute to Pseudomonas aeruginosa infections in cystic fibrosis (CF) patients, according to a study of the prevalence and clinical relevance of Pf phage in two patient cohorts. CDC/ Janice Haney Carr A n.

International Consensus Guidelines for the Optimal Use of the Polymyxins
https://accpjournals.onlinelibrary.wiley.com/doi/full/10.1002/phar.2209

Feb 1st, 2019 - The polymyxin antibiotics colistin (polymyxin E) and polymyxin B became available in the 1950s and thus did not undergo contemporary drug development procedures. Their clinical use has recently resurged, assuming an important role as salvage thera...

FDA Panel Gives High Sign for New CF Drug
https://www.medpagetoday.com/pulmonology/cysticfibrosis/34590

Sep 5th, 2012 - An FDA advisory committee voted 13-1 to recommend approval for a dry-powder formulation of tobramycin to treat pulmonary Pseudomonas aeruginosa infections in cystic fibrosis patients. Although agency staff had questioned the product's efficacy and...

Verona Integron-Encoded Metallo-β-Lactamase–Producing Carbapenem-Resistant Pseudomonas Aeruginosa Infections in U.S. Residents Associated With Invasive Medical Procedures in Mexico, 2015–2018
https://www.staging.medscape.com/viewarticle/913569

Verona integron-encoded metallo-β-lactamase–producing carbapenem-resistant Pseudomonas aeruginosa (VIM-CRPA) and other carbapenemase-producing organisms represent an emerging U.S. public health threat because of high levels of antibiotic resistanc...

The Pseudomonas aeruginosa Conundrum
https://www.medscape.com/viewarticle/744774

Abstract and Introduction Abstract The use of combination antibiotic therapy for severe pseudomonal infections is a standard practice in many hospitals; however, the data supporting its use are somewhat unclear. Possible benefits of combination th...

see more →